MNPR - Monopar Therapeutics Inc
IEX Last Trade
2.38
0.010 0.420%
Share volume: 17,167
Last Updated: Fri 30 Aug 2024 09:59:47 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$2.37
0.01
0.42%
Summary score
22%
Profitability
18%
Dept financing
1%
Liquidity
50%
Performance
25%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2015 - 30-Jun-2019
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-24.08%
Return on assets
-11.81%
Return on sales
0%
Return on invested capital
-173.62%
Total debt ratio
4.58%
Debt ratio change over timeo
-1.02%
Current Ratio
23.15%
Quick Ratio
0%
Cash Position Ratio
22.7%
Short-term ratios 30-Jun-2018 - 30-Jun-2019
The data are presented for the financials results of the quarters of the last year.
Return on equity
-15.71%
Return on assets
-15.23%
Return on sales
0%
Return on invested capital
504.8%
Total debt ratio
6.73%
Debt ratio change over timeo
-0.99%
Current Ratio
16.27%
Quick Ratio
0%
Cash Position Ratio
15.69%
Last quarter ratios 30-Jun-2019
The data are presented for the financials results of the last quarter.
Return on equity
-17.67%
Return on assets
-16.66%
Return on sales
0%
Return on invested capital
932.18%
Total debt ratio
8.37%
Debt ratio change over time
-0.99%
Current Ratio
11.16%
Quick Ratio
0%
Cash Position Ratio
10.95%
Performance ratios (change over 4 years) 30-Jun-2015 - 30-Jun-2019
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-82.77%
Return on assets
-96.14%
Return on sales
0%
Return on invested capital
320.33%
Total debt ratio
-101.54%
Debt ratio change over time
-1.02%
Current Ratio
-16.28%
Quick Ratio
0%
Cash Position Ratio
-16.09%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | MNPR | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -24.08% | 7.93% | 9% | 5.98% |
| Return on assets | -11.81% | 3.76% | 3.48% | 5.46% |
| Return on sales | 0% | 33.41% | 43.65% | 32.91% |
| Return on invested capital | -173.62% | 4.14% | 8.26% | 11.53% |
| Profitability | 0% | 67% | 84% | 85% |
| Total debt ratio | 4.58% | 98.61% | 69.57% | 30.27% |
| Debt ratio change over time | -1.02% | 16.01% | 4.97% | 1.86% |
| Dept financing | 1% | 50% | 25% | 11% |
| Current Ratio | 16.27% | 1.03% | 2.88% | 4.24% |
| Quick Ratio | 0% | 0.92% | 2.63% | 3.47% |
| Cash Position Ratio | 15.69% | 0.43% | 0.64% | 1.8% |
| Liquididy | 50% | 10% | 30% | 25% |
| Short-term ratios | MNPR | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -15.71% | -27.93% | 16.74% | 5.95% |
| Return on assets | -15.23% | 3.23% | 3.83% | 4.51% |
| Return on sales | 0% | 23.99% | 41.75% | 29.82% |
| Return on invested capital | 504.8% | 3.17% | 12.06% | 13% |
| Profitability | 25% | 32% | 72% | 52% |
| Total debt ratio | 6.73% | 111.86% | 81.19% | 26.26% |
| Debt ratio change over time | -0.99% | 11.83% | 5.7% | 2.07% |
| Dept financing | 2% | 50% | 30% | 10% |
| Current Ratio | 16.27% | 1.03% | 2.88% | 4.24% |
| Quick Ratio | 0% | 0.92% | 2.63% | 3.47% |
| Cash Position Ratio | 15.69% | 0.43% | 0.64% | 1.8% |
| Liquididy | 50% | 9% | 24% | 34% |